Indica Labs: Looking Back at 2025
recent articles
OptraSCAN: AI-Powered Cytology Platform Expands Access and Accuracy for Cervical Cancer Screening Across Asia—Aligned with WHO’s 90-70-90 Elimination Goals SINGAPORE, August 5, 2025 /EINPresswire.com/ -- OptraSCAN, a global leader in...
EVIDENT: Expanded product offering propels digital pathology from simply creating images to generating new insights for pathologists WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Evident announces a definitive agreement to acquire Pramana,...
AiosynQC and IVDR-certified Aiosyn Mitosis Breast are now available through Pathomation’s AI Marketplace, building on their AWAKE project collaboration to transform kidney diagnostics with AI. Antwerp, Belgium, and Nijmegen, Netherlands...
ROCHESTER, Minn. — Mayo Clinic took a pivotal step toward integrating AI solutions in the clinical setting with the deployment of NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems, an advanced infrastructure that provides state-of-the-art...
OREM, UT, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Techcyte, a leader in AI-powered digital pathology, has signed a distribution agreement with Hamamatsu Corporation (U.S.). This agreement enables Techcyte to streamline access to...
Paige: Oncoclínicas&Co Utilizes Paige’s AI-Assisted Diagnostic Applications to Enhance Diagnostic Capabilities and Further Support Patient Safety NEW YORK & SÃO PAULO--(BUSINESS WIRE)--Paige, a leader in...
